why choose us

First received: July 21, 2022

Clinical Trial: Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Pilot Study to Identify Radiogenomic Biomarkers to Predict Early Treatment Response to Androgen Deprivation Therapy and Radiation Therapy in High Risk Prostate Cancer

Brief Summary: The purpose of this study is to evaluate the imaging and gene expression biomarkers in prostate cancer.Participants have high-risk prostate cancer and have indicated they will undergo external beam radiation therapy, brachytherapy, and androgen deprivation therapy (EBRT+BTX+ADT).Participants can expect to be in this study for up to 5 years.

Read more